YG
Yvonne Greenstreet (Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $11.5M of ALNY (25,455 sh across 19 lots, as filed), executed Nov 12 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.8M
shares × price, as filed
Last traded
Mar 4
Filed Mar 6
Median ADV $470.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $43.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
ALNYRecent filings
ALNYSALE
Alnylam Pharmaceuticals, Inc.
View filing →
$880K3,612 sh across 4 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $483K
1,994 sh across 3 lots
Exec Feb 28 2025
Filed Mar 3 2025 · 5:30 PM ET ALNYSALE Alnylam Pharmaceuticals, Inc. View filing → $1.2M
4,826 sh across 3 lots
Exec Nov 26 2024
Filed Nov 27 2024 · 5:30 PM ET